Drug Channels

JANUARY 19, 2021

The 17th Annual Life Sciences Accounting & Reporting Congress , an important event for finance, accounting and business leaders within life sciences, provides in-depth CPE education and networking with nearly 600 professionals. Cannot be combined with special category rate or non-profit rates.

Life Science 52

Life Science Clinical Trials Clinical Trials Drugs 52

pharmaphorum

MAY 20, 2021

BMS wants to harness Exscientia’s tech to discover small-molecule drugs across a range of therapeutic categories – including immunology and oncology – and is promising another $125 million in near- and mid-term milestones to the project if all goes well. All told, the value of the deal could be as much as $1.2

Drugs 69

Drugs Pharma Companies Clinical Trials Clinical Trials 69

pharmaphorum

AUGUST 26, 2021

A merger between two digital mental health companies – Headspace and Ginger – will create a $3 billion giant in a category that has been growing at breakneck speed as a result of the COVID-19 pandemic. The company raised $100 million in a Series E financing in March, bringing its total funding to more than $220 million.

Clinical Trials 122

Clinical Trials Clinical Trials Trials 122

Drug Channels

SEPTEMBER 20, 2021

Cannot be combined with special category rates or other offers. Visit www.informaconnect.com/gtn for further details and to register. Drug Channels readers will save 10% off when they use code 21DRCH10 and register prior to October 20th.*. View the agenda to see the complete picture – agenda, speakers, and more! Other restrictions may apply.

Life Science 66

Life Science Production Drugs 66

pharmaphorum

MAY 5, 2022

One key example is the recently-introduced Access to Prescription Digital Therapeutics Act of 2022, which aims to officially define prescription digital therapeutics (PDTx) at the federal level and establish new Medicare and Medicaid benefit categories for the category. Dr Tryggvi Thorgeirsson.

Business Development 52

Business Development Medicine Production Marketing 52

Drug Channels

JUNE 14, 2021

The Life Sciences Accounting & Reporting Congress Mid-Year Critical Update provides three comprehensive days of CPE accredited content, showcasing insights and expertise from top finance, accounting, and business leaders from across the life sciences sector. Cannot be combined with special category rate or non-profit rates.

Life Science 40

Life Science Drugs Production Marketing 40

The Pharma Data

JULY 22, 2021

The company will have a strong portfolio of brands including Sensodyne, Voltaren, Panadol and Centrum and will hold category leadership positions and major sales presences in the US and China. Together with the many talented people we have in our business, I am looking forward to our exciting future as an independent company.

Branding 52

Branding Sales Engineer Production 52

pharmaphorum

JULY 14, 2021

Lilly had previously acquired a 14% stake in Protomer – which was set up in 2015 by California Institute of Technology bioengineering scientist Alborz Mahdavi – in a financing round that also included the investment arm of type 1 diabetes advocacy group JDRF.

Insulin 98

Insulin Protein Production Sales 98

The Pharma Data

MARCH 17, 2022

The Better Life Farming Alliance (BLF) supports smallholder farmers to improve their livelihoods / Bayer is a part of the BLF global alliance along with the International Finance Corporation (IFC) – a member of the World Bank Group –, Netafim – a global irrigation specialist, and more than 30 local partners / Opening of first BLF Center in Mexico.

Life Science 52

Life Science Production Branding Sales 52

pharmaphorum

OCTOBER 29, 2021

Hinge Health has become one of the top-valued companies in the digital health sector after securing a whopping $600 million in a fifth financing round. MSK conditions have become a key target for the digital health sector, and Hinge Health is just one company active in this category.

Packaging 52

Packaging Packaging Manufacturing Development 52

Drug Discovery World

MARCH 16, 2023

Investment zones The government confirmed plans for 12 low-tax ‘investment zones’ across the UK, with the aim of creating new business clusters focused around universities and research institutions. The new R&D tax credits scheme will be welcomed by small and medium sized companies. Each zone will receive £80m of support over five years.

Life Science 97

Life Science Regulation Medicine Research 97

Delveinsight

JULY 22, 2021

The decision gave Bayer complete control of BlueRock’s cell therapy pipeline, headed by DA01 and spanning various diseases in the neurology , cardiology , and immunology categories. To do so, Omniscient will utilize the financing to expand market access for its existing brain-mapping platforms, in part by increasing its global sales team.

Cardiology 98

Cardiology Development Engineer Clinical Trials 98

pharmaphorum

JUNE 16, 2021

UK-based artificial intelligence pioneer Exscientia has made a play to stay at the forefront of the field, acquiring Austrian rival Allcyte with the help of its recent $525 million financing. A string of other partnerships – including a $1.2

Drugs 59

Drugs Development Research Production 59

XTalks

FEBRUARY 2, 2021

Thus, giving your business more incentive to invest in digital channels. . Of course, knowing your audience thoroughly will assist you in drawing the right customers at the right time to your business. For many, routines, working practices and peer interactions have changed overnight. Shift Toward Digital Due To COVID-19. What’s more?

Marketing 98

Marketing Branding Sales Production 98

The Pharma Data

NOVEMBER 3, 2020

–( BUSINESS WIRE )– Ocular Therapeutix , Inc. The Panel has accepted the addition of a permanent Category I CPT procedure code to replace the currently available Category III CPT code (0356T) for the administration of drug-eluting intracanalicular inserts, including DEXTENZA® (dexamethasone ophthalmic insert) 0.4

Clinical Trials 52

Clinical Trials Clinical Trials FDA Approval Production 52

XTalks

JANUARY 22, 2021

We feel the ready-to-eat category in the plant-based space is underexplored. Kitskitchen will join Modern Meat’s line of 100 percent vegan, GMO-free meat alternatives and its newest line of dairy alternative milk , featuring Oat M*lk, Almond M*lk and Barista Edition Alternative M*lk.

Branding 59

Branding Production Bacteria Sales 59

XTalks

OCTOBER 5, 2023

It acts as a distinguished benchmark, reflecting the growth and accomplishments of businesses across the Americas. The company has received over $10 million in funding across various rounds and it is growing at a CAGR of 140 percent, ranking 49th overall on Financial Times ’ list and first in the healthcare category. title in 2015.

Pharmacy 52

Pharmacy Life Science Engineer Gene 52

Roots Analysis

JANUARY 28, 2024

Velocity: Big Data needs to be handled promptly as businesses generate data at an unprecedented speed, driven by the growing adoption of Internet of Things (IoT), and technologies, such as RFID tags, sensors, and smart meters are used to deal with the high velocity of data in real-time. It is loosely arranged into categories using meta tags.

Big Data 40

Big Data Medicine Marketing Clinical Trials 40

The Pharma Data

JANUARY 18, 2021

a clinical-stage biotechnology company focused on developing treatments for immunological and inflammatory diseases, today announced its launch backed by $80 million Series C financing led by Abingworth LLP. . SOUTH SAN FRANCISCO, Calif. , 19, 2021 /PRNewswire/ — Vera Therapeutics, Inc. ,

Development 52

Development Life Science Protein Clinical Development 52

The Pharma Data

DECEMBER 1, 2020

–( BUSINESS WIRE )– Genesis Therapeutics , a company pioneering AI technologies to create medicines for patients with severe and unmet medical needs, has completed its $52M Series A financing round. 2, 2020 11:00 UTC. BURLINGAME, Calif.–( Rock Springs Capital led the round. Rowe Price Associates, Inc., Feinberg, Ph.D.,

Development 40

Development Drugs Engineer FDA Approval 40

The Pharma Data

NOVEMBER 27, 2020

(the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer, today announced that the U.S. Food and Drug Administration (“FDA”) has approved Danyelza (naxitamab-gqgk) 40mg/10ml.

FDA Approval 52

FDA Approval Production Clinical Trials Clinical Trials 52

The Pharma Data

NOVEMBER 4, 2020

While we saw an encouraging improvement in business trends during the quarter, the outlook remains uncertain as a second wave of the pandemic impacts various countries around the world. All product groups declined compared to prior year, with Laboratory sales being the most impacted category. Q3 20 Summary Results (GAAP).

Sales 40

Sales Production Manufacturing Marketing 40

The Pharma Data

OCTOBER 19, 2020

High growth across all product categories and geographies. In addition to strong organic growth across all product segments and geographies, consolidation of the most recent acquisitions of Danaher life science businesses and of Biological Industries contributed around 4 percentage points to sales growth. percent.

Sales 52

Sales Production Manufacturing Development 52

The Pharma Data

FEBRUARY 8, 2021

and business EPS growth of 9.8% Leveraged business EPS as the result of prioritization within R&D and continued execution on smart spending initiatives. and business EPS flat on a reported basis, as a result of the overall adverse impact from foreign currency rates. Business EPS of €5.86, up 3.9% to €982 million).

Sales 52

Sales Vaccination Vaccine Production 52

The Pharma Data

FEBRUARY 4, 2021

and business EPS growth of 9.8% Leveraged business EPS as the result of prioritization within R&D and continued execution on smart spending initiatives. and business EPS flat on a reported basis, as a result of the overall adverse impact from foreign currency rates. Business EPS of €5.86, up 3.9% to €982 million).

Sales 52

Sales Vaccination Vaccine Production 52

The Pharma Data

APRIL 27, 2021

Strong increase in Q1 2021 business EPS ( 1) at CER. Q1 2021 business EPS ( 1) growth at CER driven by efficiency and sales performance, supported by a one-time payment. Business EPS ( 1) was €1.61 Business EPS ( 1) includes an incremental 8 cents due to a payment related to the termination of a collaboration in Japan.

Sales 52

Sales Vaccination Vaccine Medicine 52

Roots Analysis

OCTOBER 22, 2023

These therapeutics are broadly classified into two categories, namely coding RNAs and non-coding RNAs. RNA therapeutics are a novel class of biopharmaceuticals that harness the power of RNA molecules for the treatment and prevention of a wide range of disorders, including oncological, and genetic disorders as well as infectious diseases.

RNA 40

RNA Protein Genetics Gene Expression 40

Pharma Marketing Network

NOVEMBER 4, 2020

So tell me a little bit about the company and you’re offering and how you got started in this space? Tom (AC): Yeah sure.

Branding 52

Branding Marketing Regulation Production 52

The Pharma Data

NOVEMBER 24, 2020

–(BUSINESS WIRE)–Nov. FDA Approves Oxlumo (lumasiran) for the Treatment of Primary Hyperoxaluria Type 1. CAMBRIDGE, Mass.–(BUSINESS 24, 2020– Alnylam Pharmaceuticals, Inc. Nasdaq:ALNY), the leading RNAi therapeutics company, announced today that the U.S. President of R&D at Alnylam.

FDA Approval 52

FDA Approval Production RNA Medicine 52

World of DTC Marketing

MARCH 30, 2022

In 2019, when the Senate Finance Committee considered a drug pricing bill crafted by Sen. in traditional categories like hospitals, prescription drugs and doctors, and clinical services through 2024, while pandemic-related effects like COVID vaccines, testing and treatment, and expanded Medicaid coverage fall off. For example, Sen.

Drugs 189

Drugs Doctors Doctor Vaccination 189